---
title: "Pyronaridine - Malaria, vivax"
sidebar: mydoc_sidebar
permalink: db12975-mesh-d016780-1.html
toc: false 
---


Path ID: `DB12975_MESH_D016780_1`
{% include image.html url="images/db12975-mesh-d016780-1.png" file="db12975-mesh-d016780-1.png" alt="db12975-mesh-d016780-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C027871 | Pyronaridine | Drug |
| GO:0042540 | hemoglobin catabolic process | BiologicalProcess |
| MESH:D006418 | Heme | ChemicalSubstance |
| NCBITaxon:5855 | Plasmodium vivax | OrganismTaxon |
| MESH:D016780 | Malaria, Vivax | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pyronaridine | NEGATIVELY REGULATES | Hemoglobin Catabolic Process |
| Hemoglobin Catabolic Process | INCREASES ABUNDANCE OF | Heme |
| Heme | DISRUPTS | Plasmodium Vivax |
| Plasmodium Vivax | CAUSES | Malaria, Vivax |
|---------|-----------|---------|

Reference: 
  - [https://www.ema.europa.eu/en/documents/medicine-outside-eu/pyramax-product-information_en.pdf](https://www.ema.europa.eu/en/documents/medicine-outside-eu/pyramax-product-information_en.pdf)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483207/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483207/)

Reference: 
  - [https://www.ema.europa.eu/en/documents/medicine-outside-eu/pyramax-product-information_en.pdf](https://www.ema.europa.eu/en/documents/medicine-outside-eu/pyramax-product-information_en.pdf)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483207/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483207/)
